Lys9 for Glu9 substitution in glucagon-like peptide-1(7–36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9–36)amide and exendin (9–39)

Publication | Closed Access

DOI

Citations

References

2004

Year

BD Green, MH Mooney, Victor A. Gault, Nigel Irwin, Clifford J. Bailey, Patrick Harriott, Brett Greer, Peter R. Flatt, Finbarr O’Harte

Metabolism

Molecular PharmacologyBiochemistryNatural SciencesMedicinePeptide LibraryMolecular BiologyIv ResistancePeptide TherapeuticPeptide SciencePeptide TherapeuticsCellular BiochemistryAmide ConfersGlu9 Substitution